Prescient Therapeutics LimitedASX: PTX

FDA Allows PTX IND for Leukemia Phase Ib & II Trials

Feb 11, 2016 at 1:19 AM UTC · Issued by Prescient Therapeutics Limited

Prescient Therapeutics Limited has released a press release.

View Attachment